BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 15, 2021
View Archived Issues
Omega selects OTX-2002 as development candidate for MYC-driven HCC
Read More
Chi3l1/YKL-40 as therapeutic target to slow the progression of AD
Read More
Positive interim data from controlled study of KB-109 in outpatients with COVID-19
Read More
FDA clears IND application for phase I/IIa study of VOR-33 in AML
Read More
First patient enrolled in phase IIb VISTAS study of volixibat in adults with PSC
Read More
CanSino Biologics patents glycoconjugates as vaccines for pneumococcal infections
Read More
Array BioPharma discloses BRAF mutant inhibitors
Read More
IL-37 and IL-1R8 deficiencies contribute to the pathogenesis of necrotizing enterocolitis
Read More
Binding of NAD+ to the ARM domain in SARM1 self-inhibits SARM1 to avoid axonal degeneration
Read More
Investigators present new antibodies for malaria
Read More
Japanese researchers propose Lister hooded rats as a new model of ADHD
Read More
Chinese approval of Rykindo for schizophrenia and psychotic states
Read More
CJ-2360 achieves complete tumor regression in ALK-positive xenografts
Read More
Bimagrumab improves traits in patients with type 2 diabetes and obesity
Read More
Glutamine aids and abets senescent cell survival
Read More
New classification scheme for glioblastomas
Read More
Mis-spliced RNAs in tumor cells trigger antiviral response
Read More
PW-0787, a novel potent and brain-penetrant GPR52 agonist for neuropsychiatric disorders
Read More
FDA approves Xalkori for ALK-positive ALCL in children and young adults
Read More
PK/PD effect studies evaluating differences in clinical efficacy of LEO-29102 and LEO-39652
Read More
Phase I/II results for COVID-19 vaccine Ad26.COV2.S support its further development
Read More
